BioCentury
ARTICLE | Financial News

Myovant completes IPO

October 31, 2016 7:00 AM UTC

Myovant Sciences Ltd. (NYSE:MYOV), Hamilton, BermudaBusiness: Genitourinary, Cancer, Endocrine/MetabolicDate completed: 2016-10-27Type: IPORaised: $217.5 millionShares: 14.5 millionPrice: $15Shares af...